Gliomatosis peritonei arising in setting of immature ovarian teratoma: A case report

2019 ◽  
Vol 11 (1) ◽  
pp. 04-06
Author(s):  
Meghna Das ◽  
◽  
Pranita Thakuria ◽  
Mridusmita Das ◽  
Manoj Kumar ◽  
...  
2005 ◽  
Vol 42 (3) ◽  
pp. 165 ◽  
Author(s):  
R Sharma ◽  
S Thulkar ◽  
S Mukhopadhyay ◽  
D Deka ◽  
R Mannan ◽  
...  

2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Anu Bajracharya ◽  
Suraj Shrestha ◽  
Moushumi Singh ◽  
Hari Prasad Dhakal

2002 ◽  
Vol 16 (3) ◽  
pp. 207-211 ◽  
Author(s):  
A. Soto Moreno ◽  
E. M. Venegas ◽  
J. R. Rodriguez ◽  
F. Sánchez ◽  
M. J. Robles ◽  
...  

2014 ◽  
Vol 25 (3) ◽  
pp. 339-343 ◽  
Author(s):  
Laura A. Adamson-Small ◽  
Larry J. Fowler ◽  
Jacqueline A. Hobbs

Author(s):  
Nandakishore Thokchom ◽  
Nandita Bhattacharjee ◽  
Linda Kongbam

<p class="abstract">Bleomycin is an antitumour antibiotic commonly used in the management of Hodgkin’s lymphoma and germ cell tumours. Flagellate pigmentation is a very specific and rare cutaneous adverse effect of bleomycin. It is characterised by linear, painless, pruritic, hyperpigmented lesions simulating marks of whiplashes over trunk and extremities. With the advent of targeted therapies resulting in the infrequent use of bleomycin, this unique side effect is also uncommonly encountered nowadays. Here, we report a case of bleomycin-induced flagellate pigmentation in a 35-year-old Indian female with ovarian teratoma. The characteristic patterned hyperpigmented patches developed following 2nd cycle of chemotherapy with bleomycin, etoposide and cisplatin.</p><p class="abstract"> </p>


2021 ◽  
Vol 7 (2) ◽  
pp. 132
Author(s):  
Sangeeta Pankaj ◽  
Kavya Abhilashi ◽  
Pratibha Kumari ◽  
Satya Kumari ◽  
Jyotsna Rani ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document